• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个整合的转录调控回路,增强乳腺癌干细胞状态。

An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state.

机构信息

Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

出版信息

Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14470-5. doi: 10.1073/pnas.1212811109. Epub 2012 Aug 20.

DOI:10.1073/pnas.1212811109
PMID:22908280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3437881/
Abstract

Cancer stem-like cells (CSCs) are a highly tumorigenic cell type present as a minority population in developmentally diverse tumors and cell lines. Using a genetic screen in an inducible model of CSC formation in a breast cell line, we identify microRNAs (miRNAs) that inhibit CSC growth and are down-regulated in CSCs. Aside from the previously identified miR-200 family, these include the miR-15/16 (miR-16, miR-15b) and miR-103/107 (miR-103, miR-107) families as well as miR-145, miR-335, and miR-128b. Interestingly, these miRNAs affect common target genes that encode the Bmi1 and Suz12 components of the polycomb repressor complexes as well as the DNA-binding transcription factors Zeb1, Zeb2, and Klf4. Conversely, expression of the CSC-modulating miRNAs is inhibited by Zeb1 and Zeb2. There is an inverse relationship between the levels of CSC-regulating miRNAs and their respective targets in samples from triple-negative breast cancer patients, providing evidence for the relevance of these interactions in human cancer. In addition, combinatorial overexpression of these miRNAs progressively attenuates the growth of CSCs derived from triple-negative breast cancers. These observations suggest that CSC formation and function are reinforced by an integrated regulatory circuit of miRNAs, transcription factors, and chromatin-modifying activities that can act as a bistable switch to drive cells into either the CSC or the nonstem state within the population of cancer cells.

摘要

癌症干细胞样细胞 (CSCs) 是一种高度致瘤性的细胞类型,作为少数群体存在于发育多样化的肿瘤和细胞系中。我们在诱导型乳腺癌细胞系 CSC 形成模型中使用遗传筛选,鉴定了抑制 CSC 生长且在 CSCs 中下调的 microRNAs (miRNAs)。除了先前鉴定的 miR-200 家族外,这些 miRNA 还包括 miR-15/16 (miR-16、miR-15b) 和 miR-103/107 (miR-103、miR-107) 家族以及 miR-145、miR-335 和 miR-128b。有趣的是,这些 miRNAs 影响常见的靶基因,这些靶基因编码多梳抑制复合物的 Bmi1 和 Suz12 成分以及 DNA 结合转录因子 Zeb1、Zeb2 和 Klf4。相反,CSC 调节 miRNA 的表达受 Zeb1 和 Zeb2 的抑制。三阴性乳腺癌患者样本中 CSC 调节 miRNA 的水平与其各自靶基因之间存在负相关关系,为这些相互作用在人类癌症中的相关性提供了证据。此外,这些 miRNA 的组合过表达逐渐减弱了源自三阴性乳腺癌的 CSCs 的生长。这些观察结果表明,CSC 的形成和功能是由 miRNA、转录因子和染色质修饰活性的综合调控回路加强的,该回路可以作为双稳态开关,将细胞驱动到癌细胞群体中的 CSC 或非干细胞状态。

相似文献

1
An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state.一个整合的转录调控回路,增强乳腺癌干细胞状态。
Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14470-5. doi: 10.1073/pnas.1212811109. Epub 2012 Aug 20.
2
Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells.miR-200 抑制 Suz12 的丧失导致多梳介导的抑制,这是癌症干细胞形成和维持所必需的。
Mol Cell. 2010 Sep 10;39(5):761-72. doi: 10.1016/j.molcel.2010.08.013.
3
MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.miRNA 调控的乳腺细胞分化过程中的基因网络与乳腺癌相关。
Carcinogenesis. 2012 Aug;33(8):1502-11. doi: 10.1093/carcin/bgs161. Epub 2012 May 4.
4
Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?胚胎干细胞微小RNA:诱导多能干细胞(iPS)和癌症干细胞(CSC)的决定性因素?
Curr Stem Cell Res Ther. 2009 Sep;4(3):168-77. doi: 10.2174/157488809789057400.
5
miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4.miR-7 通过调节 KLF4 抑制乳腺癌干细胞样细胞的脑转移。
Cancer Res. 2013 Feb 15;73(4):1434-44. doi: 10.1158/0008-5472.CAN-12-2037. Epub 2013 Feb 5.
6
miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes.miR-200 通过抑制多个 Zeb2 和 Snail1 转录抑制复合物成员促进间充质到上皮的转化。
Oncogene. 2016 Jan 14;35(2):158-72. doi: 10.1038/onc.2015.69. Epub 2015 Mar 23.
7
The miR-200b-ZEB1 circuit regulates diverse stemness of human hepatocellular carcinoma.miR-200b-ZEB1 信号通路调控人肝细胞癌的多种干性。
Mol Carcinog. 2017 Sep;56(9):2035-2047. doi: 10.1002/mc.22657. Epub 2017 Apr 18.
8
miR-29a-KLF4 signaling inhibits breast tumor initiation by regulating cancer stem cells.miR-29a-KLF4 信号通过调节肿瘤干细胞抑制乳腺癌起始。
Int Immunopharmacol. 2024 Mar 30;130:111797. doi: 10.1016/j.intimp.2024.111797. Epub 2024 Mar 4.
9
miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells.miR-221 靶向 QKI 以增强人结直肠肿瘤干细胞的致瘤能力。
Cancer Res. 2019 Oct 15;79(20):5151-5158. doi: 10.1158/0008-5472.CAN-18-3544. Epub 2019 Aug 15.
10
A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.一种多梳蛋白-mir200环调控膀胱癌的临床结局。
Oncotarget. 2015 Dec 8;6(39):42258-75. doi: 10.18632/oncotarget.5546.

引用本文的文献

1
SE-lncRNAs in Cancer: Classification, Subcellular Localisation, Function and Corresponding TFs.癌症中的SE-lncRNAs:分类、亚细胞定位、功能及相应转录因子
J Cell Mol Med. 2024 Dec;28(24):e70296. doi: 10.1111/jcmm.70296.
2
Regulation of IGF1R by MicroRNA-15b Contributes to the Anticancer Effects of Calorie Restriction in a Murine C3-TAg Model of Triple-Negative Breast Cancer.微小RNA-15b对IGF1R的调控有助于热量限制在三阴性乳腺癌小鼠C3-TAg模型中的抗癌作用。
Cancers (Basel). 2023 Aug 29;15(17):4320. doi: 10.3390/cancers15174320.
3
Current understanding of cancer stem cells: Immune evasion and targeted immunotherapy in gastrointestinal malignancies.癌症干细胞的当前认识:胃肠道恶性肿瘤中的免疫逃逸与靶向免疫治疗
Front Oncol. 2023 Feb 23;13:1114621. doi: 10.3389/fonc.2023.1114621. eCollection 2023.
4
miR-145-5p Targets Sp1 in Non-Small Cell Lung Cancer Cells and Links to BMI1 Induced Pemetrexed Resistance and Epithelial-Mesenchymal Transition.miR-145-5p 在非小细胞肺癌细胞中靶向 Sp1,并与 BMI1 诱导的培美曲塞耐药和上皮-间充质转化相关。
Int J Mol Sci. 2022 Dec 5;23(23):15352. doi: 10.3390/ijms232315352.
5
Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells.乳腺癌干细胞的生物标志物和内源性调控的研究进展。
Cells. 2022 Sep 20;11(19):2941. doi: 10.3390/cells11192941.
6
NPC1 Confers Metabolic Flexibility in Triple Negative Breast Cancer.NPC1赋予三阴性乳腺癌代谢灵活性。
Cancers (Basel). 2022 Jul 21;14(14):3543. doi: 10.3390/cancers14143543.
7
Breast Cancer; Discovery of Novel Diagnostic Biomarkers, Drug Resistance, and Therapeutic Implications.乳腺癌;新型诊断生物标志物的发现、耐药性及治疗意义
Front Mol Biosci. 2022 Feb 21;9:783450. doi: 10.3389/fmolb.2022.783450. eCollection 2022.
8
Transcriptional control of a collagen deposition and adhesion process that promotes lung adenocarcinoma growth and metastasis.转录控制胶原沉积和黏附过程,促进肺腺癌生长和转移。
JCI Insight. 2022 Jan 11;7(1):e153948. doi: 10.1172/jci.insight.153948.
9
The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer.黄酮类化合物通过 miRNA 调控对三阴性乳腺癌的抗癌作用。
Nutrients. 2021 Apr 7;13(4):1212. doi: 10.3390/nu13041212.
10
MicroRNA Regulation of Breast Cancer Stemness.微小RNA对乳腺癌干性的调控
Int J Mol Sci. 2021 Apr 4;22(7):3756. doi: 10.3390/ijms22073756.

本文引用的文献

1
IL6-mediated suppression of miR-200c directs constitutive activation of inflammatory signaling circuit driving transformation and tumorigenesis.IL6 介导的 miR-200c 抑制作用指导炎症信号通路的组成性激活,驱动转化和肿瘤发生。
Mol Cell. 2012 Mar 30;45(6):777-89. doi: 10.1016/j.molcel.2012.01.015. Epub 2012 Feb 23.
2
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.miR-200s 通过直接靶向 Sec23a 影响癌细胞分泌组并促进转移定植。
Nat Med. 2011 Aug 7;17(9):1101-8. doi: 10.1038/nm.2401.
3
miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells.miR-200a 调节乳腺上皮细胞中的 SIRT1 表达和上皮间质转化(EMT)样转化。
J Biol Chem. 2011 Jul 22;286(29):25992-6002. doi: 10.1074/jbc.M111.229401. Epub 2011 May 19.
4
Targets of miR-200c mediate suppression of cell motility and anoikis resistance.miR-200c 的靶标介导细胞迁移的抑制和抗失巢凋亡。
Breast Cancer Res. 2011 Apr 18;13(2):R45. doi: 10.1186/bcr2867.
5
Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types.二甲双胍可降低化疗剂量,从而延长涉及多种癌细胞类型的小鼠异种移植物肿瘤缓解时间。
Cancer Res. 2011 May 1;71(9):3196-201. doi: 10.1158/0008-5472.CAN-10-3471. Epub 2011 Mar 17.
6
MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer.微小 RNA-335 通过遗传和表观遗传机制抑制人类乳腺癌的肿瘤再起始和沉默。
Genes Dev. 2011 Feb 1;25(3):226-31. doi: 10.1101/gad.1974211.
7
The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells.ZEB1/miR-200 反馈环路控制癌细胞中的 Notch 信号通路。
EMBO J. 2011 Feb 16;30(4):770-82. doi: 10.1038/emboj.2010.349. Epub 2011 Jan 11.
8
Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion.通过白细胞介素 6(IL6)分泌诱导乳腺癌干细胞的形成及其与非干细胞癌细胞的动态平衡。
Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1397-402. doi: 10.1073/pnas.1018898108. Epub 2011 Jan 10.
9
Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells.miR-200 抑制 Suz12 的丧失导致多梳介导的抑制,这是癌症干细胞形成和维持所必需的。
Mol Cell. 2010 Sep 10;39(5):761-72. doi: 10.1016/j.molcel.2010.08.013.
10
STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer.STAT3 通过 PTEN 和 CYLD 激活 miR-21 和 miR-181b-1,是将炎症与癌症联系起来的表观遗传开关的一部分。
Mol Cell. 2010 Aug 27;39(4):493-506. doi: 10.1016/j.molcel.2010.07.023.